We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Febrile Rhabdomyolysis Diagnosed in West African Refugees

By LabMedica International staff writers
Posted on 13 Sep 2017
Rhabdomyolysis is a complex medical condition involving the rapid breakdown of damaged skeletal muscle. More...
The severity of the illness ranges from asymptomatic elevations of serum creatine phosphokinase (CPK) to life-threatening diseases such as cardiac arrhythmia, acute renal failure, and even death.

There were 153,842 people who arrived directly in Italy via the sea in 2015 and 181,436 people in 2016, mainly coming from Nigeria, Eritrea, Guinea, Ivory Coast, Gambia, Senegal, Mali, and Sudan. An increasing number of cases of febrile rhabdomyolysis have been observed in these migrants since May 2014, and so far there has been no specific etiological diagnosis.

Scientists at the University of Brescia and Spedali Civili General Hospital (Brescia, Italy) and their associates performed a multicenter retrospective observational study of cases of febrile rhabdomyolysis reported from May 2014 to December 2016 in 12 Italian centers: nine infectious diseases and tropical medicine units, two internal medicine units, and one refugee center. A total of 48 cases were identified; 43 were male (89.6%), and their mean age was 22.4 ± 5.8 years. Febrile rhabdomyolysis was defined as an increase in creatine phosphokinase levels (≥1000 IU/L) associated with myalgia and fever (>38 °C). They all came from West Africa, mainly from Nigeria (58.3%). All patients were hospitalized with fever and very intense muscle aches. Creatine phosphokinase, aspartate aminotransferase, and lactate dehydrogenase values were abnormal in all cases.

The rhabdomyolysis was ascribed by the treating physicians to an infective agent in 16 (33.3%) cases. In detail, Epstein–Barr virus (EBV) DNA was detected in eight of 32 patients tested, immunoglobulin M (IgM) for coxsackievirus was detected in five of 27 cases tested, and IgM for cytomegalovirus was identified in three of 29 cases tested. The etiology was undefined in the remaining cases. The most frequent infectious causes of rhabdomyolysis were excluded. Four out of seven patients who were tested for abnormal hemoglobin had sickle cell trait (SCT) and one patient had hemophilia A.

The authors concluded that the long incubation period from when the refugees left Libya and arrived in Italy does not support a mechanical cause of rhabdomyolysis. Furthermore, viral infections such as those caused by coxsackievirus are rarely associated with such a severe clinical presentation. They hypothesized that other predisposing conditions like genetic factors, unknown infections, or unreported non-conventional remedies may be involved. Therefore targeted surveillance of rhabdomyolysis cases is warranted. The study was published online on July 26, 2017, in the International Journal of Infectious Diseases.

Related Links:
Spedali Civili General Hospital


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.